| | Call Details | Derma Sciences Earnings Conference Call (Q1 2008) Thu,
May 15, 2008, 11:00 am Eastern
| | About Derma Sciences
(OTC BB:DSCI.OB) |
| | Derma Sciences, Inc., together with its subsidiaries, manufactures, markets, and sells dermatological products in the United States, Canada, and internationally. The companys wound care products include dressings, devices, ointments, and sprays to manage and treat various skin conditions, such as basic burns, skin tears, abrasions, and incontinence related skin impairment, as well as chronic non-healing skin ulcerations, including pressure, diabetic, and venous ulcers, and surgical incisions and serious burns. Its private label wound care, wound closure, and specialty securement devices include wound closure strips, nasal tube fasteners, and various catheter fasteners. The company also offers general purpose and specialized skin care products, including bath sponges, antibacterial skin cleansers, soaps, hair and body washes, lotions, body oil, and moisturizers. Derma Sciences has two development stage products, GUARDION Barrier Dressings with an antimicrobial, which is under review by the FDA for marketing clearance, for use in various gauzes and traditional wound care dressings; and DSC127, an angiotensin analog that completed a phase I human trial for use in wound healing and scar reduction. Its customers include various health care agencies and institutions, such as clinics, nursing homes, hospitals, home healthcare agencies, physicians offices, retail and closed door pharmacies, and other institutions, as well as doctors. The company sells its products through direct sales force, distributors, and licensing and distribution agreements. Derma Sciences was founded in 1984 and is headquartered in Princeton, New Jersey. |
| More
Info:
Quote
|
Chart
|
News
|
Profile
|
Reports
|
Research
|
SEC
|
Insider
|
Financials
|
Analyst Ratings |
|